Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.

Inzaule SC, Hamers RL, Noguera-Julian M, Casadellà M, Parera M, Kityo C, Steegen K, Naniche D, Clotet B, Rinke de Wit TF, Paredes R, PanAfrican Studies to Evaluate Resistance

Open source

DOI
10.1016/s2352-3018(18)30177-2
Published
2018 Nov
Container
The lancet. HIV
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-18-30177-2,
  title = {Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.},
  author = {Inzaule SC and Hamers RL and Noguera-Julian M and Casadellà M and Parera M and Kityo C and Steegen K and Naniche D and Clotet B and Rinke de Wit TF and Paredes R and PanAfrican Studies to Evaluate Resistance},
  year = {2018},
  journal = {The lancet. HIV},
  doi = {10.1016/s2352-3018(18)30177-2},
  url = {https://doi.org/10.1016/s2352-3018(18)30177-2}
}

RIS

TY  - JOUR
TI  - Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
AU  - Inzaule SC
AU  - Hamers RL
AU  - Noguera-Julian M
AU  - Casadellà M
AU  - Parera M
AU  - Kityo C
AU  - Steegen K
AU  - Naniche D
AU  - Clotet B
AU  - Rinke de Wit TF
AU  - Paredes R
AU  - PanAfrican Studies to Evaluate Resistance
PY  - 2018
JO  - The lancet. HIV
DO  - 10.1016/s2352-3018(18)30177-2
UR  - https://doi.org/10.1016/s2352-3018(18)30177-2
ER  - 

APA

SC, I., RL, H., M, N., M, C., M, P., C, K., K, S., D, N., B, C., TF, R. D. W., R, P., & Resistance, P. S. T. E. (2018). Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(18)30177-2

Source records